Skip to main content
. Author manuscript; available in PMC: 2024 Jan 31.
Published in final edited form as: Exp Clin Psychopharmacol. 2022 Feb 3;31(1):163–173. doi: 10.1037/pha0000543

Table 2.

Summary of Moderation Analyses Predicting Membership in the AUD (vs. no AUD) Group

Variable of interest b SE z p 95% CI

Model 1: Baseline HPA-axis functioning (n = 93)
 Intercept 1.49 .74 2.02 .04 [.04, 2.94]
 Baseline HPA-axis functioning 3.71 2.30 1.62 .11 [–.79, 8.21]
 PTSD symptom severity .02 .01 1.68 .09 [–.004, .05]
 Baseline HPA-axis functioning × PTSD symptom severity .29 .14 2.04 .04 [.01, .56]
 Number of lifetime traumatic events −.02 .05 −0.34 .74 [−.11, .08]
 Time of day −.62 .37 −1.68 .09 [−1.35, .11]
 Time since last cigarette .001 .001 1.16 .24 [.00, .002]
 Current menstruation .06 .79 0.07 .94 [–1.49, 1.60]
Model 2: HPA-axis Reactivity (n = 56)
 Intercept 1.42 1.02 1.39 .17 [−.58, 3.43]
 HPA-axis reactivity −.43 5.71 −0.08 .94 [−11.62, 10.76]
 PTSD symptom severity .01 .01 0.45 .66 [−.02, .03]
 HPA-axis reactivity × PTSD symptom severity −.01 .33 −0.04 .97 [−.65, .62]
 Number of lifetime traumatic events −.01 .07 −0.17 .86 [−.14, .12]
 Time of day −.59 .43 −1.38 .17 [−1.42, .25]
 Time since last cigarette .00 .001 −0.17 .87 [−.002, .002]
 Current menstruation .59 .94 0.62 .53 [–1.25, 2.43]
Model 3: HPA-axis recovery (n = 55)
 Intercept 3.00 1.41 2.12 .03 [.23, 5.76]
 HPA-axis recovery −13.20 10.52 −1.26 .21 [−33.82, 7.42]
 PTSD symptom severity .01 .02 0.59 .55 [−.02, .04]
 HPA-axis recovery × PTSD symptom severity −1.64 .73 −2.25 .02 [−3.07, −.21]
 Number of lifetime traumatic events −.06 .07 −0.82 .41 [−.21, .08]
 Time of day −1.22 .56 −2.17 .03 [−2.32, −.12]
 Time since last cigarette .00 .001 0.05 .96 [−.002, .002]
 Current menstruation −.89 1.17 −0.76 .45 [−3.99, 1.40]

Note. Bolded typeface indicates significance at the level p < .05. AUD = alcohol use disorder; HPA = hypothalamic–pituitary–adrenal; PTSD = posttraumatic stress disorder.